On the one hand, Th17 cells can induce immunosuppression and increase tumor angiogenesis, but they also mediate antitumor immune responses through recruitment of immune cells into tumors, stimulating effector CD8+ T cells [39]. The gene discussed is CD8A; the disease is neoplasm.